Chat with us, powered by LiveChat
Continuing Education for Pharmacists and Pharmacy Technicians
Pharmacy CE
ACPE Accredited Continuing Education for Pharmacists and Pharmacy Technicians

Managing Menopause: A Hot Topic Webcast – 1 CE

Activity Overview

Menopause is an inevitable life event for all females. The peri-menopausal transition can have dramatic effects on female systemic health, cognition, mood, energy, and quality of life. The approach to management requires a thoughtful understanding of both the risks and benefits associated with treatment. For years, hormone replacement therapy was looked at as a fountain of youth, a treatment that could minimize troublesome menopause symptoms, enhance bone growth, and improve quality of life through effects on mood and cognition. Theorizing this possible benefit, the Women’s Health Initiative Trial was implemented, with the hypothesis that HRT would dramatically reduce risks of CVD and cancer in postmenopausal women. Interestingly, the WHI was stopped prematurely due to an increased risk of CVD and breast cancer in certain populations. After this trial, the use of hormone therapy fell dramatically, and estrogen and progestin-based therapies to treat menopause largely fell out of favor, posing that the risks of HRT did not outweigh the benefits. Almost twenty years after the WHI, clinicians remain hesitant to implement systemic hormone therapy for patients with peri-menopausal symptoms, and the results of the study still spark debate in the medical community. This is likely due to the notion that conflicting thoughts, and perspectives still prevail, and there is a lack of clear, consensus guidelines on the approach to management.The availability of recent trial data that demonstrate differing outcomes of hormone replacement therapy based upon patient characteristics should not be overlooked, as new data suggests that the benefits of HRT in improving quality of life, reducing bone loss, and reducing peri-menopausal symptoms can outweigh the risks in certain patients. The purpose of this session is to introduce the attendee to the previous viewpoints on HRT, the recent clinical trial data that has rebuked many previous perspectives, and discuss hot topics in the treatment of menopause including Vitamin D therapy, osteoporosis, management of CVD, and finally the emotional toll of menopause with a focus on effects on mood, cognition, and depression. This session will provide individuals a comprehensive understanding on appropriate candidates for hormonal and non- hormonal therapies for menopause, and how to minimize the impeding effects of menopause to enhance quality of life.

Pharmacist Learning Objectives

At the conclusion of this continuing education activity, the participant will be able to:

  1. Describe the spectrum of symptoms present in a perimenopausal female
  2. Analyze the risk/benefit ratio of hormone replacement therapy for the management of postmenopausal symptoms
  3. Recommend therapeutic regimens for the management of perimenopausal vasomotor symptoms

     BUY NOW

Accreditation Statement

ACPEAchieveCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

AchieveCE is also accredited by the Florida Board of Pharmacy (provider no. 50-20641). This course is approved by CE Broker, with CE Broker No. 20-846343.

Faculty Information

Lalita Prasad-Reddy, PharmD, MS, BCPS, BCACP, CDECS is Assistant Dean for Student Affairs and Associate Professor of Pharmacy Practice at Chicago State University College of Pharmacy. Dr. Prasad-Reddy received her PharmD degree from Creighton University and her Masters in Health Communication from Boston University. She completed a PGY1 residency at the University of Chicago Medical Center and a PGY2 specialty residency in ambulatory care at Butler University College of Pharmacy/Indiana University Health in 2010. Currently, she maintains a clinical practice at Rush University Internists where she is an ambulatory care specialist managing patients with chronic care disease states. She is also the Associate Discipline Director of Pharmacology at Rush Medical College. Dr. Prasad-Reddy’s clinical and academic interests include cardiovascular risk reduction, endocrinology, women’s health, health communication, and outreach, and education disparities. She is the recipient of multiple accolades including the Teacher of the Year as well as Preceptor of the Year from Chicago State University and in 2020 was named Educator of the Year by the Illinois Pharmacists Association.

Financial Support Disclosure

This activity was developed by AchieveCE free of any commercial support.

Content Complexity

  Level 2. Basic Application of Skills and Concepts

Delivery Type

Home Study Webcast



1 Contact Hour


Disease State Management/Drug Therapy

Target Audience


Activity Type


Universal Activity Number


Activity Release Date

July 14, 2021

Activity Expiration Date

July 14, 2024



Handout Download Link(s)

Already a Member?

Requirements for Credit

Participants must score a passing grade of 70% or higher on the activity post-test and complete an activity evaluation. There are no time limits and unlimited test-taking attempts. Credits will be reported automatically to CPE Monitor and/or CE Broker if your license information is entered properly in your profile.

CE Broker Reporting

If you are licensed under a board supported by CE Broker, feel free to log into your CE Broker account to view your reported courses or to contact their support staff.

Hardware Requirements

Windows 8.1, Windows 10
Mac OS X 10.1 or higher
iOS 10+, Android 4.3+

Software Requirements

Google Chrome, Microsoft Edge, Mozilla Firefox
Adobe Acrobat Reader

Network Requirements

Broadband Internet Connection:
T1, Hi-speed DSL or Cable
4G cellular connection

Get Unlimited CE!

Get unlimited CE for one low annual fee.
Save time and money by becoming a member!

Need more Pharmacy CEs?

Check out other live webinars and home study activities to study at your own time!